New England Securities’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$222K Buy
9,911
+900
+10% +$23.4K 0.08% 251
2014
Q3
$247K Buy
9,011
+1,280
+17% +$38.7K 0.09% 235
2014
Q2
$246K Buy
7,731
+3,035
+65% +$90.3K 0.09% 256
2014
Q1
$121K Sell
4,696
-810
-15% -$22.1K 0.05% 356
2013
Q4
$143K Buy
5,506
+2,090
+61% +$58.4K 0.06% 328
2013
Q3
$93K Buy
3,416
+450
+15% +$14.1K 0.05% 365
2013
Q2
$108K Buy
+2,966
New +$107K 0.07% 280

Other funds holding CLMT

New England Securities's CLMT Position: Q4 2014 in Review

New England Securities increased its Calumet Specialty Products (CLMT) stake by 10% in Q4 2014, buying an estimated $23.4K and bringing the position to 9,911 shares worth $222K. The position accounts for 0.08% of the portfolio, ranked #251.

New England Securities first reported a position in CLMT in Q2 2013 and has held it in 7 quarters since. The position peaked at $247K in Q3 2014. 118 funds tracked by Wall St. Rank hold CLMT as of Q4 2014.

  • New England Securities held 9,911 shares of Calumet Specialty Products worth $222K as of Q4 2014.
  • New England Securities bought 900 Calumet Specialty Products shares in Q4 2014, an estimated $23.4K.
  • Calumet Specialty Products made up 0.08% of New England Securities's portfolio in Q4 2014, its #251 holding.
  • New England Securities first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 7 quarters since.
  • New England Securities's Calumet Specialty Products position peaked at $247K in Q3 2014.
  • 118 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.